Monocyte-derived dendritic cells from HLA-B27+ axial spondyloarthritis (SpA) patients display altered functional

Abstract

Insights

Monocyte-derived dendritic cells (MD-DCs) from HLA-B27+ axial spondyloarthritis (SpA) patients show reduced T cell stimulatory capacity and altered gene expression. The Wnt signaling pathway is implicated in SpA pathogenesis.

Area of Science:

  • Immunology
  • Genetics
  • Rheumatology

Background:

  • Axial spondyloarthritis (SpA) is an inflammatory disease associated with HLA-B27.
  • Monocyte-derived dendritic cells (MD-DCs) play a crucial role in immune responses.
  • The functional and molecular characteristics of MD-DCs in HLA-B27+ SpA remain incompletely understood.

Purpose of the Study:

  • To compare the functional capacity of MD-DCs in HLA-B27+ SpA patients versus healthy controls.
  • To analyze the gene expression profile of MD-DCs in HLA-B27+ SpA patients compared to controls.
  • To investigate potential molecular pathways involved in MD-DC dysfunction in SpA.

Main Methods:

  • MD-DCs were differentiated from CD14+ monocytes using IL-4 and GM-CSF.
  • Functional capacity was assessed by allogeneic CD4+ T cell stimulation.
  • Transcriptomic analysis was performed using microarrays, with validation by qRT-PCR.

Main Results:

  • MD-DCs from SpA patients exhibited decreased capacity to stimulate allogeneic CD4+ T cells.
  • Transcriptomic analysis identified 81 differentially expressed genes in SpA MD-DCs.
  • Expression of ADAMTS15 and CITED2 was inversely correlated, and Wnt signaling pathway genes were co-regulated with CITED2.

Conclusions:

  • HLA-B27+ SpA is associated with altered MD-DC function and gene expression patterns.
  • An inverse correlation between ADAMTS15 and CITED2 expression was observed in SpA MD-DCs.
  • Deregulation of the Wnt signaling pathway in SpA MD-DCs may contribute to Th17-driven inflammation.